Synthetic biology is moving at a rapid pace, and regulations will need to keep up to allow useful technologies to hit the market while maintaining a high standard of safety. Since most policymakers are not experts in all of the newest synthetic biology technologies, better analysis tools are needed to understand how to react. So two researchers, Christopher Cummings and Jennifer Kuzma, from North Carolina State University and Nanyang Technological University built a model to determine how to prepare for handling the regulation new synthetic biology products.
Building a model for governing new synbio technology
This model for assessing risks of new synthetic biology technologies is called Societal Risk Evaluation Scheme (SRES) and it tries to make governance more anticipatory than just reactive. This is a tough problem. How do we predict the risks of technologies that don’t exist yet? How do we assess products that seem totally new? The field of synthetic biology is pushing the boundaries of what we can do with and to biology.
Reproduced Fig 1. Visual Representation of Slovic’s (1987) Known/Controllable Dimensions of Risk
http://dx.doi.org/10.1371/journal.pone.0168564.g001
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Aggregated News
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.
